Page 7,007«..1020..7,0067,0077,0087,009..7,0207,030..»

Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

Posted: Published on March 15th, 2012

EDMONDS, Wash., March 14, 2012 /PRNewswire/ --Washington Center for Pain Management is participating in a nationwide FDA-cleared adult stem cell study testing novel treatment for chronic low back pain and has enrolled its first patient. The study will test the use of Mesenchymal Precursor Cells (MPCs) adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. The minimally invasive procedure may offer an alternative to back surgery for eligible patients with chronic pain from degenerative discs. An estimated 30 million people in the United States suffer from back pain. Degenerative disc disease is the most common cause of low-back pain, which develops with the gradual loss of a material called proteoglycan, which cushions the bones of the spine and enables normal motion. Most patients with low-back pain respond to physical therapy and medications, but in advanced cases, artificial disc replacement or spinal fusion -- removal of the degenerated discs and the fusion of the bones of the spine -- is necessary. However, these surgeries often are not entirely effective. "Millions of Americans are debilitated by chronic low back pain," says Dr Hyun Joong Hong MD, the lead investigator at The Washington Center for Pain … Continue reading →

Comments Off on Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

BioTime Announces Fourth Quarter and Fiscal Year End 2011 Financial Results and Recent Corporate Accomplishments

Posted: Published on March 14th, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the fourth quarter and year ended December 31, 2011 and highlighted recent corporate accomplishments. At the forefront of our corporate strategy is a plan to develop and acquire novel technologies in the stem cell field and to establish one of the broadest sets of capabilities in the industry. We made significant strides towards the accomplishment of that goal through further development of our products and through key strategic acquisitions in 2011. We are now positioned to focus on commercializing these emerging technologies, said Michael D. West, Ph.D., BioTime's President and CEO. We are on track to begin human clinical trials in 2012 for HyStem-Rx as a medical device for the delivery of adipose stem cells for reconstructive surgery and transplantation, and we look forward to providing updates on our progress of this and other important product development programs during 2012, including the PanC-DxTM cancer diagnostic development program. Financial Results Revenue For the quarter ended December 31, 2011, on a consolidated basis, total revenue was $1.6 million, up $0.2 million or 15% from $1.4 … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on BioTime Announces Fourth Quarter and Fiscal Year End 2011 Financial Results and Recent Corporate Accomplishments

Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

Posted: Published on March 14th, 2012

EDMONDS, Wash., March 14, 2012 /PRNewswire/ --Washington Center for Pain Management is participating in a nationwide FDA-cleared adult stem cell study testing novel treatment for chronic low back pain and has enrolled its first patient. The study will test the use of Mesenchymal Precursor Cells (MPCs) adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. The minimally invasive procedure may offer an alternative to back surgery for eligible patients with chronic pain from degenerative discs. An estimated 30 million people in the United States suffer from back pain. Degenerative disc disease is the most common cause of low-back pain, which develops with the gradual loss of a material called proteoglycan, which cushions the bones of the spine and enables normal motion. Most patients with low-back pain respond to physical therapy and medications, but in advanced cases, artificial disc replacement or spinal fusion -- removal of the degenerated discs and the fusion of the bones of the spine -- is necessary. However, these surgeries often are not entirely effective. "Millions of Americans are debilitated by chronic low back pain," says Dr Hyun Joong Hong MD, the lead investigator at The Washington Center for Pain … Continue reading →

Comments Off on Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

Perry's stem-cell firm draws FDA scrutiny

Posted: Published on March 14th, 2012

The U.S. Food and Drug Administration has received a complaint alleging the Houston company involved in Gov. Rick Perry's unregulated adult stem-cell operation is a potential danger to patients and not in compliance with federal law. In an eight-page letter sent last month, University of Minnesota bioethicist Leigh Turner called on the FDA to investigate Celltex Therapeutics Corp., which banks people's stem cells for future reinjection in the event of disease or injury. Perry was the company's first customer last year. "It appears their business plan involves injecting or infusing on a for-profit, commercial basis non-FDA-approved adult stem cells into paying customers," Turner wrote in the Feb. 21 letter. "This plan conflicts with FDA regulations governing human stem cells." An FDA spokeswoman declined comment, but Turner said an agency official told him the matter has been assigned to an investigator and is being taken seriously. Celltex co-founder David Eller said Tuesday night he is confident the company will "meet all FDA specifications." He emphasized that Celltex doesn't administer stem cells, but stores and processes them at the behest of doctors who later reinject them into patients. Dr. Stanley Jones, a Houston orthopedic surgeon, injected Perry's stem cells during his back … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Perry's stem-cell firm draws FDA scrutiny

Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

Posted: Published on March 14th, 2012

EDMONDS, Wash., March 14, 2012 /PRNewswire/ --Washington Center for Pain Management is participating in a nationwide FDA-cleared adult stem cell study testing novel treatment for chronic low back pain and has enrolled its first patient. The study will test the use of Mesenchymal Precursor Cells (MPCs) adult stem cells derived from bone marrow that will be directly injected into the lumbar disc. The minimally invasive procedure may offer an alternative to back surgery for eligible patients with chronic pain from degenerative discs. An estimated 30 million people in the United States suffer from back pain. Degenerative disc disease is the most common cause of low-back pain, which develops with the gradual loss of a material called proteoglycan, which cushions the bones of the spine and enables normal motion. Most patients with low-back pain respond to physical therapy and medications, but in advanced cases, artificial disc replacement or spinal fusion -- removal of the degenerated discs and the fusion of the bones of the spine -- is necessary. However, these surgeries often are not entirely effective. "Millions of Americans are debilitated by chronic low back pain," says Dr Hyun Joong Hong MD, the lead investigator at The Washington Center for Pain … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Washington Center for Pain Management Begins Enrollment in United States Stem Cell Therapy Study in Subjects With …

ACT Announces Filing of Definitive Proxy

Posted: Published on March 14th, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that on Monday, March 12 it filed with the Securities and Exchange Commission a proxy statement containing a shareholder proposal for a reverse split of its common stock. The annual meeting of stockholders will be held on Thursday, April 26, at the Hyatt Regency Suites, Palm Springs, 285 N. Palm Canyon Dr.,Palm Springs,Calif.,92262, on Thursday,April 26,2012, at 9 a.m. PDT, to consider the following proposals: election of five directors, ratifying the appointment of the companys public accounting firm, and a proposal to effect a reverse stock split of the companys common stock, at a ratio between one-for-twenty and one-for-eighty, and to reduce the number of authorized shares of the companys common stock in the same proportion as the reverse split, with the exact ratio to be determined by the board of directors. This reverse stock split, which should better align the companys capital structure with its stage of development, and an accompanying Nasdaq listing application, will represent a significant step toward creating long-term shareholder value and building ACT into a world-class player in the regenerative medicine space, said Gary Rabin, … Continue reading →

Posted in Cell Medicine | Comments Off on ACT Announces Filing of Definitive Proxy

How About Requiring Rectal Exams for Viagra Prescriptions?

Posted: Published on March 14th, 2012

By Sam Favate In what is shaping up to be the latest chapter in the womens rights movement, female legislators across the country are introducing bills to regulate mens health, in an effort to combat several anti-abortion and anti-contraception laws that have been popping up with increasing regularity. In Ohio, Nina Turner, a Democrat, introduced a bill that would limit a mans ability to get a Viagra prescription without meeting certain conditions, including psychological counseling and written information from doctors about the potential risks. Turner said shes been outraged by bills and amendments over the last few years that impact a womans right to contraception and to an abortion, according to the Huffington Post. Turner also cautions that her bill shouldnt be seen as a joke: Im just as serious as a heart attack, she said. Last month in Oklahoma, State Senator Constance Johnson, a Democrat, introduced an amendment to the so-called personhood bill that would declare it an act against unborn children to waste sperm. In Illinois, Rep. Kelly Cassidy introduced an amendment to a mandatory ultrasound bill that would require men to watch a graphic video about the side effects of Viagra before being able to get a … Continue reading →

Posted in Prescriptions | Comments Off on How About Requiring Rectal Exams for Viagra Prescriptions?

USAA, Amazon.com, Costco, Virgin America, Apple, Trader Joe's and Wegmans Among the Highest in Customer Loyalty in the …

Posted: Published on March 14th, 2012

SAN MATEO, Calif., March 14, 2012 /PRNewswire/ --Satmetrix, the Net Promoter software company and leader in customer experience programs, today released its 2012 Net Promoter Industry Benchmarks for the financial services, insurance, online services, retailing, technology, telecommunications, and travel and hospitality industries. This year's study was expanded to reach more than 30,000 U.S. consumers, with ratings for more than 200 brands across 22 industry sectors. This year's study includes new coverage for auto service and repair, drug stores and pharmacies, hardware and home supply stores, hotels, and travel websites. Winners include admired brands such as USAA, Amazon.com, Costco, Virgin America, Apple, Trader Joe's and Wegmans. (Logo: http://photos.prnewswire.com/prnh/20120202/NY46467LOGO ) The Satmetrix Net Promoter Benchmarks are based on survey responses from U.S. consumers nationwide who rate their experience with the primary brands they use. The Net Promoter Score, or NPS, for each brand is based on customers' likelihood to recommend the company's product or service in the sector being rated. NPS is calculated as the percentage of customers who are promoters, rating the company 9 or 10 on a 0 to 10 point scale, minus the percentage who are detractors, rating 6 or lower.Consumers also rate each brand on various aspects of … Continue reading →

Posted in Wholesale Pharmacy | Comments Off on USAA, Amazon.com, Costco, Virgin America, Apple, Trader Joe's and Wegmans Among the Highest in Customer Loyalty in the …

H. D. Smith Appoints Bill Williams Chief Financial Officer

Posted: Published on March 14th, 2012

SPRINGFIELD, Ill., March 14, 2012 /PRNewswire/ --H. D. Smith, among the nation's largest pharmaceutical wholesalers, today announced the appointment of Bill Williams as company-wide chief financial officer (CFO).Mr. Williams, who served recently as the Company's interim CFO, will report to chairman and chief executive Dale Smith, and joins the executive leadership committee.The appointment is effective immediately. (Photo: http://photos.prnewswire.com/prnh/20120314/NY69737 ) "Bill has brought perspective to this pharmaceutical wholesale enterprise that elevates our customer excellence and accelerates our growth plan," said Dale Smith, chairman and CEO, H. D. Smith."Best practices shared from many Fortune 500 companies are quickly becoming part of our working culture and Bill's ideas and abilities are making a significant impact," he added. Mr. Williams comes to H. D. Smith from Tatum LLC, a leading national firm specializing in interim executive staffing. In this capacity, he served as a partner in the Tatum Chicago office.During his career, Mr. Williams has served in financial oversight roles at multiple Fortune 500 companies including Kraft Foods, Allied Signal and Martin Brower Company (the largest McDonald's Corporation distributor in the Americas). "H. D. Smith is at the heart of supporting our nation's health and wellness through an extensive partnership with community and institutional … Continue reading →

Posted in Wholesale Pharmacy | Comments Off on H. D. Smith Appoints Bill Williams Chief Financial Officer

Drug addition: Faith communities working with addicts

Posted: Published on March 14th, 2012

Watch a video, read more about the series and available treatment groups. Related story: Drug problem meant isolation. Faith communities have known there were plenty of people trapped in addiction sitting in the pews, afraid to suffer the shame that would come from sharing their problems. But some places of worship are now offering or hosting recovery programs, minimizing the stigma. "People in the church are just as broken as people who are not in the church, and a lot of times we are good at masking that and faking it," said Micah Hobbs, who oversees the Celebrate Recovery ministry at Memorial Road Church of Christ. "But the reality is that we are all broken and are in need of healing and hope, encouragement and support." While Celebrate Recovery programs have started in a variety of Christian churches, many houses of faith have long been supporters of 12-step recovery programs such as Alcoholics Anonymous. Some faith groups have developed programs to teach clergy and laity about addiction and treatment. Annette Harper directs addiction ministries for the Oklahoma Conference of the United Methodist Church, which offers an education program and support group. The church started its Summer School on Chemical Dependency … Continue reading →

Posted in Drug Dependency | Comments Off on Drug addition: Faith communities working with addicts

Page 7,007«..1020..7,0067,0077,0087,009..7,0207,030..»